Canada markets closed

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.80-0.08 (-0.81%)
At close: 04:00PM EDT
9.80 0.00 (0.00%)
After hours: 05:04PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.90B
Enterprise Value 3.11B
Trailing P/E N/A
Forward P/E 72.99
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.90
Price/Book (mrq)22.21
Enterprise Value/Revenue 7.34
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 3-19.67%
S&P500 52-Week Change 323.49%
52 Week High 314.57
52 Week Low 39.02
50-Day Moving Average 310.49
200-Day Moving Average 311.78

Share Statistics

Avg Vol (3 month) 32.84M
Avg Vol (10 day) 32.3M
Shares Outstanding 5296.2M
Implied Shares Outstanding 6296.2M
Float 8238.52M
% Held by Insiders 10.72%
% Held by Institutions 1109.61%
Shares Short (May 15, 2024) 428.91M
Short Ratio (May 15, 2024) 49.78
Short % of Float (May 15, 2024) 49.82%
Short % of Shares Outstanding (May 15, 2024) 49.76%
Shares Short (prior month Apr 15, 2024) 431.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -34.73%
Operating Margin (ttm)-19.63%

Management Effectiveness

Return on Assets (ttm)-5.08%
Return on Equity (ttm)-126.10%

Income Statement

Revenue (ttm)423.49M
Revenue Per Share (ttm)1.42
Quarterly Revenue Growth (yoy)28.00%
Gross Profit (ttm)N/A
EBITDA -49.02M
Net Income Avi to Common (ttm)-147.07M
Diluted EPS (ttm)-0.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)239.6M
Total Cash Per Share (mrq)0.81
Total Debt (mrq)444.49M
Total Debt/Equity (mrq)340.10%
Current Ratio (mrq)3.04
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)-80.72M
Levered Free Cash Flow (ttm)-37.5M